Sector revisions H. Lundbeck A/S

Stocks

Market Closed - Nasdaq Copenhagen Other stock markets 08:50:00 10/07/2026 pm IST			5-day change	1st Jan Change
42.48 ^DKK	-1.16%		-1.48%	-1.58%

18/06	Nordea raises target price for Lundbeck to DKK60 (57), reiterates buy rating	FW
15/06	H. Lundbeck A/S Presents Preliminary Phase II Part A Data for Asedebart in Cushing's Disease	CI

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	H. LUNDBECK A/S							12
	MCKESSON CORPORATION							15
	CARDINAL HEALTH, INC.							15
	SIGMA HEALTHCARE LIMITED							15
	SHANGHAI PHARMACEUTICALS HOLDING CO., LTD							8
	HUADONG MEDICINE CO., LTD							9
	SINOPHARM GROUP CO. LTD.							14
	GALENICA AG							5
	JOINTOWN PHARMACEUTICAL GROUP CO., LTD							4
	MEDIPAL HOLDINGS CORPORATION							4
	CHINA NATIONAL MEDICINES CORPORATION LTD.							2
	SELÇUK ECZA DEPOSU TICARET VE SANAYI							4
	EBOS GROUP LIMITED							8
	SUZUKEN CO., LTD.							3
	QINGDAO BAHEAL MEDICAL INC.							1
	CHINA NATIONAL ACCORD MEDICINES CORPORATION LTD.							5
	TOHO HOLDINGS CO., LTD.							2
	UNIPHAR PLC							8
	Average							7
	Weighted average by Cap.							13